Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Wallace Rivers who wrote (17936)	10/27/2003 9:23:46 PM
From: Spekulatius	Respond to of 78752

MEDI- I've been tempted by this, but I am not sold on Flumist prospects. Dosage is way more expensive than a shot. I saw an ad last night on TV during prime time, I was very unimpressed. The production IMHO was amateurish, and half of the ad, it seemed was devoted to disclaimers about the population that was at risk and shouldn't use it. Not the greatest way to market a product, It may be true that Flumist is a wildcard at this point but i think that MEDI is worth its current valuation even without Flumist. I think that WYE will get its marketing right sooner or later. I intend to add to my position below 25$ if it ever gets that low.